Branka Radic Sarikas

Cited by

	All	Since 2019
Citations	1098	654
h-index	11	9
i10-index	11	9

140

105

2013201420152016201720182019202020212022202320246 23 89 91 129 98 99 119 135 121 114 66

Public access

View all

11 articles

1 article

available

not available

Based on funding mandates

Co-authors

Giulio Superti-FurgaScientific Director, CeMM Research Center for Molecular Medicine of the Austrian Academy ofVerified email at cemm.oeaw.ac.at
Kilian V. M. HuberPrincipal Investigator, University of OxfordVerified email at cmd.ox.ac.uk
Heinrich KovarVerified email at ccri.at
Keiryn L. BennettsciGig Scientific Consulting & Editing e.U.Verified email at scigig.eu
ColingeIRCM, Université de Montpellier, ICMVerified email at inserm.fr
Alexey StukalovSeer, Inc.Verified email at seer.bio
Georg E WinterPrincipal Investigator at CeMM, ViennaVerified email at cemm.oeaw.ac.at
Stefan KubicekCeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesVerified email at cemm.oeaw.ac.at
Stefan KnappUniversity of FrankfurtVerified email at pharmchem.uni-frankfurt.de
Thomas HelledayKarolinska InstitutetVerified email at ki.se
Joanna LoizouDirector of Translational Medicine, Early Oncology, AstraZenecaVerified email at astrazeneca.com
Thijn BrummelkampGroupleader, Netherlands Cancer InstituteVerified email at nki.nl
Søren BrunakProfessor of Disease Systems Biology, University of CopenhagenVerified email at cpr.ku.dk
Kalliopi TsafouData Sciences & Quantitative Biology, AstraZenecaVerified email at astrazeneca.com
Lucia Altucci, MD, PhDSeconda Università di NapoliVerified email at unina2.it
Oscar Fernandez-CapetilloGenomic Instability Group, Spanish National Cancer Research Centre (CNIO)Verified email at cnio.es
Robert KralovicsPrincipal Investigator, Medical University of ViennaVerified email at meduniwien.ac.at
Doris ChenMax Perutz Labs, University of Vienna, AustriaVerified email at univie.ac.at
Richard Kumaran Kandasamy, Ph.D.Departments of Laboratory Medicine, and Quantitative Health Sciences, Mayo ClinicVerified email at mayo.edu
Claudia Jessen-TrefzerUniversity of Freiburg / Cluster of Excellence CIBSS - Centre for Integrative Biological SignallingVerified email at pharmazie.uni-freiburg.de

Branka Radic Sarikas

Medical University of Vienna and St. Anna CCRI Children's Cancer Research Institute

Verified email at ccri.at - Homepage

life sciences


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ... Nature 508 (7495), 222-227, 2014	449	2014
The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity GE Winter, B Radic, C Mayor-Ruiz, VA Blomen, C Trefzer, RK Kandasamy, ... Nature chemical biology 10 (9), 768-773, 2014	181	2014
Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions R Martins, J Maier, AD Gorki, KVM Huber, O Sharif, P Starkl, S Saluzzo, ... Nature immunology 17 (12), 1361-1372, 2016	138	2016
The YAP/TAZ pathway in osteogenesis and bone sarcoma pathogenesis H Kovar, L Bierbaumer, B Radic-Sarikas Cells 9 (4), 972, 2020	92	2020
The second European interdisciplinary Ewing sarcoma research summit–A joint effort to deconstructing the multiple layers of a complex disease H Kovar, J Amatruda, E Brunet, S Burdach, F Cidre-Aranaz, E De Alava, ... Oncotarget 7 (8), 8613, 2016	52	2016
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells L Bierbaumer, AM Katschnig, B Radic-Sarikas, MO Kauer, JA Petro, ... Oncogenesis 10 (1), 2, 2021	42	2021
Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter B Radic-Sarikas, M Halasz, KVM Huber, GE Winter, KP Tsafou, ... Scientific Reports 7 (1), 3091, 2017	38	2017
Histone deacetylase inhibitors: clinical implications for hematological malignancies FP Tambaro, C Dell’Aversana, V Carafa, A Nebbioso, B Radic, F Ferrara, ... Clinical epigenetics 1, 25-44, 2010	27	2010
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells G Franci, L Casalino, F Petraglia, M Miceli, R Menafra, B Radic, V Tarallo, ... Biology open 2 (10), 1070-1077, 2013	26	2013
Combinatorial drug screening identifies Ewing sarcoma–specific sensitivities B Radic-Sarikas, KP Tsafou, KB Emdal, T Papamarkou, KVM Huber, ... Molecular Cancer Therapeutics 16 (1), 88-101, 2017	22	2017
Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers K Tsafou, AM Katschnig, B Radic-Sarikas, CN Mutz, K Iljin, R Schwentner, ... Oncotarget 9 (57), 31018, 2018	14	2018
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma S Grissenberger, C Sturtzel, A Wenninger-Weinzierl, B Radic-Sarikas, ... Cancer Letters 554, 216028, 2023	8	2023
Zooming in on long non-coding RNAs in ewing sarcoma pathogenesis DNT Aryee, V Fock, U Kapoor, B Radic-Sarikas, H Kovar Cells 11 (8), 1267, 2022	6	2022
Enhancing cognate target elution efficiency in gel-free chemical proteomics B Radic-Sarikas, U Rix, A Stukalov, M Gridling, AC Müller, J Colinge, ... EuPA Open Proteomics 9, 43-53, 2015	2	2015
Targeting YAP/TAZ pathway inhibits Ewing sarcoma metastasis L Bierbaumer, AM Katschnig, B Radic-Sarikas, JR Petro, K Mühlbacher, ... Cancer Research 79 (13_Supplement), 1049-1049, 2019	1	2019
In vitro modeling of pediatric solid tumor lung metastases M Zylka, C Hafemeister, L Watzke, U Mann, D Surdez, EA Sweet-Cordero, ... Cancer Research 84 (6_Supplement), 196-196, 2024		2024
YAP1 is a key regulator of EWS:: FLI1-dependent malignant transformation upon IGF-1 mediated reprogramming of bone mesenchymal stem cells H Kovar, R Noorizadeh, B Sax, T Javaheri, B Radic Sarikas, V Fock, ... bioRxiv, 2024.07. 15.603565, 2024		2024
3D-models of pediatric bone sarcomas for personalized therapeutic screening B Radic Sarikas, M Ilg, M Markovic, C Sturtzel, E Scheuringer, J Zulini, ... # PLACEHOLDER_PARENT_METADATA_VALUE# 82, 2022		2022
3D-models of pediatric bone sarcomas for personalized therapeutic screening BR Sarikas, M Ilg, M Markovic, C Sturtzel, E Scheuringer, J Zulini, ... Cancer Research 82 (12_Supplement), 6245-6245, 2022		2022
Targeted Therapy H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ... cancer strategy 508, 222-7, 2014		2014

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors